Send feedback

A2ML1 p.Val1192=

c.3576A>G · rs771118520 · VCV413829

Likely benign Multiple submitters
Classification
Likely benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 2 submitters
gnomAD v4.1
Rare
ultra-rare (popmax 0.0245%, nfe)

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP -3.3GERP -3.3
Overall
CADD0.541PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.0245% European (non-Finnish) · 289/1,180,020 alleles
Filtering AF 0.0221% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0212%
Overall 0.0183% 296/1,614,096 alleles · ultra-rare exomes 293/1,461,868 · genomes 3/152,228 · joint denominator
Ancestry group Frequency 1 in
European (non-Finnish)grpmax 0.0245% 4,083
Remaining individualsnot grpmax-eligible 0.0112% 8,927

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
A2ML1
Protein
p.Val1192=
Coding
c.3576A>G
MANE Select
NM_144670
dbSNP
rs771118520
Type
single nucleotide variant
Location
chr12:8863867 (GRCh38)
Gene constraint
LOEUF 0.953 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 80.61 · 5 PDB
Residue 1192
an α-helix; a UniProt-annotated variant site (risk factor for otitis media)
Full A2ML1 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/a2ml1-p-val1192 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown